ABSTRACT
Higher fungi (Basidiomycetes) have been heavily researched in the last two decades, which makes the beginning of the 21st century known as the age of fungiceuticals. The wide pool of in vitro and in vivo data, as well as clinical studies, promise us miraculous natural agents. However, the industry has its own stance in the case of mushroom nutraceuticals. This chapter provides the overview of different aspects of medicinal mushroom commercialization: from the explanation of this new segment of products, over proper fungal material identification, choosing the raw material, dosing, bioavailability and drug delivery systems, safety and quality, organic certification, strategies in formulating them, to emerging fields of potential use, including antiviral products. Each of these aspects is discussed from both the positive and negative side present in today's industry and market.
